Skip to main content

Table 2 Prevalence of cardiovascular risk factors (CVRF) by age category and gender in the ORISCAV-LUX study

From: First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX)

CVRF   18-69
n (%)
18-29
n (%)
30-39
n (%)
40-49
n (%)
50-59
n (%)
60-69
n (%)
P-value* P-value**
Obesity Total 325 (20.9)        
  Men 175 (23) 7 (6.3) 35 (20.3) 50 (26.6) 45 (32.9) 38 38.6) <0.0001 0.03
  Women 150 (18.7) 7 (6.7) 28 14.2) 40 (20.6) 32 (22.2) 43 (39.4)   
Hypertension Total 540 (34.5)        
  Men 322 (41.9) 10 (9.3) 50 (28.7) 95 (50.2) 86 (63.0) 81 (84.1) <0.0001 <0.0001
  Women 218 (27.1) 7 (6.3) 22 (13.1) 51 (26.7) 64 (43.5) 74 (67.8)   
Diabetes Total 69 (4.4)        
  Men 39 (5.2) 1 (1.1) 1 (0.7) 7 (3.8) 12 (8.8) 18 (18.8) <0.0001 0.08
  Women 30 (3.5%) 0 (-) 1 (0.5) 5 (2.4) 8 (5.3) 16 (14.7)   
Lipid disorder Total 1033 (69.9)        
  Men 533 (74.3) 44 (42.7) 119 (70.9) 159 (84.5) 120 (89.7) 91 (96.5) <0.0001 0.0002
  Women 500 (65.5) 48 (42.3) 93 (52.0) 124 (67.8) 136 (92.0) 99 (92.0)   
Current smoking Total 307 (22.3)        
  Men 165 (24.9) 41 (38.6) 39 (22.7) 46 (24.5) 30 (22.4) 9 (8.6) <0.0001 0.03
  Women 142 (19.7) 33 (28.7) 32 (17.3) 31 (16.7) 31 (20.3) 15 (13.0)   
R-ATPIII-defined MS Total 368 (24.0) 9 (4.4) 40 (11.6) 95 (25.5) 114 (42.1) 110 (55.1) <0.0001 <0.0001
  Men 221 (29.5) 7 (6.9) 26 (15.6) 62 (33.8) 67 (50.5) 59 (61.2)   
  Women 147 (18.4) 2 (2.0) 14 (7.5) 33 (17.1) 47 (33.3) 51 (49.4)   
  1. Results are expressed as number of cases (%). * P value for age, ** P-value for gender
\